Scot Harper
Chief Tech/Sci/R&D Officer presso RADIOPHARM THERANOSTICS LIMITED
Profilo
Scot L.
Harper is currently the Senior Vice President-Clinical Operations at Radiopharm Theranostics Ltd.
Previously, he worked as the Vice President-Clinical Operations at Endocyte, Inc. from 2013 to 2016.
Harper received his undergraduate degree from DePauw University, his graduate degree from the University of South Alabama, and his doctorate from The Indiana University School of Medicine.
Posizioni attive di Scot Harper
| Società | Posizione | Inizio |
|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Chief Tech/Sci/R&D Officer | 01/12/2021 |
Precedenti posizioni note di Scot Harper
| Società | Posizione | Fine |
|---|---|---|
| ENDOCYTE, INC. | Chief Tech/Sci/R&D Officer | 28/10/2016 |
Formazione di Scot Harper
| DePauw University | Undergraduate Degree |
| University of South Alabama | Graduate Degree |
| The Indiana University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Health Services |
| Aziende private | 1 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
- Borsa valori
- Insiders
- Scot Harper
